Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells (Q39501063)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells (English)

1 reference

Europe PubMed Central

12 September 2017

toll-like receptor

0 references

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

12 September 2017

Stephen Schoenberger

10

object named as

Stephen P Schoenberger

0 references

Stefan Nierkens

object named as

Stefan Nierkens

1

0 references

author name string

Martijn H den Brok

2

1 reference

Europe PubMed Central

12 September 2017

Zacharias Garcia

3

1 reference

Europe PubMed Central

12 September 2017

Susan Togher

4

1 reference

Europe PubMed Central

12 September 2017

Jori Wagenaars

5

1 reference

Europe PubMed Central

12 September 2017

Melissa Wassink

6

1 reference

Europe PubMed Central

12 September 2017

Louis Boon

7

1 reference

Europe PubMed Central

12 September 2017

Theo J Ruers

8

1 reference

Europe PubMed Central

12 September 2017

Gosse J Adema

11

1 reference

Europe PubMed Central

12 September 2017

Edith M Janssen

12

1 reference

Europe PubMed Central

12 September 2017

language of work or name

0 references

publication date

25 July 2011

1 reference

Europe PubMed Central

12 September 2017

Cancer Research

1 reference

Europe PubMed Central

12 September 2017

71

1 reference

Europe PubMed Central

12 September 2017

6428-6437

1 reference

Europe PubMed Central

12 September 2017

20

1 reference

Europe PubMed Central

12 September 2017

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Antigen-presentation properties of plasmacytoid dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Crosspresentation: plasmacytoid dendritic cells are in the business

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Oligodeoxynucleotide CpG 7909 delivered as intravenous infusion demonstrates immunologic modulation in patients with previously treated non-Hodgkin lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

12 September 2017

Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

14 September 2017

In vivo colocalization of antigen and CpG [corrected] within dendritic cells is associated with the efficacy of cancer immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

14 September 2017

Primary alloproliferative TH1 response induced by immature plasmacytoid dendritic cells in collaboration with myeloid DCs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

14 September 2017

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

14 September 2017

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

21 August 2018

Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

21 August 2018

Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

21 August 2018

Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

21 August 2018

Interleukin 15-dependent crosstalk between conventional and plasmacytoid dendritic cells is essential for CpG-induced immune activation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

21 August 2018

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

21 August 2018

High-intensity focused ultrasound in the treatment of solid tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

21 August 2018

Migratory Dendritic Cells Transfer Antigen to a Lymph Node-Resident Dendritic Cell Population for Efficient CTL Priming

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653311

2 December 2018

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early activation markers of human peripheral dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Image-based study of interferongenic interactions between plasmacytoid dendritic cells and HSV-infected monocyte-derived dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-presentation: avoiding trafficking chaos?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21788345

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/0008-5472.CAN-11-2154

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39501063&oldid=1832175904"